BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32611725)

  • 21. Unexpected Off-Target Activities for Recombinant C5a in Human Macrophages.
    Li XX; Gorman DM; Lee JD; Clark RJ; Woodruff TM
    J Immunol; 2022 Jan; 208(1):133-142. PubMed ID: 34853076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.
    Zhang T; Garstka MA; Li K
    J Immunol Res; 2017; 2017():8193932. PubMed ID: 28706957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.
    Thorenz A; Derlin K; Schröder C; Dressler L; Vijayan V; Pradhan P; Immenschuh S; Jörns A; Echtermeyer F; Herzog C; Chen R; Rong S; Bräsen JH; van Kooten C; Kirsch T; Klemann C; Meier M; Klos A; Haller H; Hensen B; Gueler F
    Kidney Int; 2018 Oct; 94(4):741-755. PubMed ID: 29935951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
    Zaal A; van Ham SM; Ten Brinke A
    Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The C5a/C5aR2 axis promotes renal inflammation and tissue damage.
    Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
    Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
    J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring C5aR2 Expression Using a Floxed tdTomato-C5aR2 Knock-In Mouse.
    Karsten CM; Wiese AV; Mey F; Figge J; Woodruff TM; Reuter T; Scurtu O; Kordowski A; Almeida LN; Briukhovetska D; Quell KM; Sun J; Ender F; Schmudde I; Vollbrandt T; Laumonnier Y; Köhl J
    J Immunol; 2017 Nov; 199(9):3234-3248. PubMed ID: 28864475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
    Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
    Front Immunol; 2018; 9():2035. PubMed ID: 30258440
    [No Abstract]   [Full Text] [Related]  

  • 29. TLQP-21 is a low potency partial C3aR activator on human primary macrophages.
    Li XX; Lee JD; Lee HS; Clark RJ; Woodruff TM
    Front Immunol; 2023; 14():1086673. PubMed ID: 36776827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain.
    Morgan M; Deuis JR; Woodruff TM; Lewis RJ; Vetter I
    Mol Immunol; 2018 Feb; 94():68-74. PubMed ID: 29274925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (T
    A Verghese D; Demir M; Chun N; Fribourg M; Cravedi P; Llaudo I; Woodruff TM; Yadav P; Lira SA; Medof ME; Heeger PS
    J Immunol; 2018 Mar; 200(6):2186-2198. PubMed ID: 29436411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Role for C5a in B-1 Cell Homeostasis.
    Bröker K; Figge J; Magnusen AF; Manz RA; Köhl J; Karsten CM
    Front Immunol; 2018; 9():258. PubMed ID: 29520270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Second Receptor for C5a, C5aR2, Is Detrimental to Mice during Systemic Infection with
    Mueller-Ortiz SL; Shivshankar P; Wetsel RA
    J Immunol; 2019 Nov; 203(10):2701-2711. PubMed ID: 31597707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques.
    Vijayan S; Asare Y; Grommes J; Soehnlein O; Lutgens E; Shagdarsuren G; Togtokh A; Jacobs MJ; Fischer JW; Bernhagen J; Weber C; Schober A; Shagdarsuren E
    Am J Pathol; 2014 Jul; 184(7):2123-33. PubMed ID: 24819959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
    Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
    Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational variants of the ternary complex of C5a, C5aR1, and G-protein.
    Gupta PK; Singh A; Rana S
    J Biomol Struct Dyn; 2024 Jan; ():1-16. PubMed ID: 38247266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
    Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM
    Front Immunol; 2023; 14():1197709. PubMed ID: 37275893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.
    Moreno-Fernandez ME; Aliberti J; Groeneweg S; Köhl J; Chougnet CA
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):399-408. PubMed ID: 26537334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement receptors C5aR1 and C5aR2 act differentially during the early immune response after bone fracture but are similarly involved in bone repair.
    Kovtun A; Bergdolt S; Hägele Y; Matthes R; Lambris JD; Huber-Lang M; Ignatius A
    Sci Rep; 2017 Oct; 7(1):14061. PubMed ID: 29070810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
    Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
    J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.